LOTRIMIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Lotrimin, and what generic alternatives are available?
Lotrimin is a drug marketed by Schering Plough, Schering, and Bayer Healthcare Llc. and is included in four NDAs.
The generic ingredient in LOTRIMIN is butenafine hydrochloride. There are two drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the butenafine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Lotrimin
A generic version of LOTRIMIN was approved as butenafine hydrochloride by TARO on November 16th, 2017.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LOTRIMIN?
- What are the global sales for LOTRIMIN?
- What is Average Wholesale Price for LOTRIMIN?
Summary for LOTRIMIN
| US Patents: | 0 |
| Applicants: | 3 |
| NDAs: | 4 |
| Raw Ingredient (Bulk) Api Vendors: | 126 |
| Clinical Trials: | 4 |
| Patent Applications: | 4,202 |
| DailyMed Link: | LOTRIMIN at DailyMed |
Recent Clinical Trials for LOTRIMIN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Bayer | Phase 3 |
| Taro Pharmaceuticals USA | Phase 1 |
US Patents and Regulatory Information for LOTRIMIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Schering Plough | LOTRIMIN | clotrimazole | CREAM;TOPICAL | 017619-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Bayer Healthcare Llc | LOTRIMIN ULTRA | butenafine hydrochloride | CREAM;TOPICAL | 021307-001 | Dec 7, 2001 | OTC | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Schering | LOTRIMIN | clotrimazole | LOTION;TOPICAL | 018813-001 | Feb 17, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Schering Plough | LOTRIMIN | clotrimazole | SOLUTION;TOPICAL | 017613-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for LOTRIMIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Schering Plough | LOTRIMIN | clotrimazole | CREAM;TOPICAL | 017619-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
| Schering | LOTRIMIN | clotrimazole | LOTION;TOPICAL | 018813-001 | Feb 17, 1984 | ⤷ Sign Up | ⤷ Sign Up |
| Schering | LOTRIMIN | clotrimazole | LOTION;TOPICAL | 018813-001 | Feb 17, 1984 | ⤷ Sign Up | ⤷ Sign Up |
| Schering Plough | LOTRIMIN | clotrimazole | SOLUTION;TOPICAL | 017613-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for LOTRIMIN
See the table below for patents covering LOTRIMIN around the world.
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
